Riscos relacionados à utilização de ozempic® (semaglutide) para o emagrecimento

Abstract

The search for quick solutions for weight loss leads many to turn to Ozempic® (Semaglutide), a medication originally indicated for the treatment of type 2 diabetes. Despite its effectiveness in controlling blood glucose levels, the use for weight loss generates several health risks that need to be considered. Gastrointestinal, cardiovascular, renal and other effects such as fatigue, dehydration, changes in vision, hypothyroidism, potential for abuse and misuse of the mentioned drug. Weight loss with Semaglutide can be significant, but not sustainable in the long term, as discontinuation of the medication leads to weight regain. Long-term studies on the safety and effectiveness of Semaglutide for weight loss are still scarce. Nonpharmacological measures such as a balanced diet and regular physical activity are essential for healthy and sustainable weight loss. Assessment by a healthcare professional is essential to developing a safe and effective plan that takes into account individual needs. Prioritizing safety and well-being should be the basis for any decision about obesity treatment.